Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Recombinant human monoclonal antibody of the IgG1 kappa class against prostate stem cell antigen

EU orphan designation number: EU/3/12/1090
Active ingredient: Recombinant human monoclonal antibody of the IgG1 kappa class against prostate stem cell antigen
Indication: Treatment of pancreatic cancer
Sponsor: Astellas Pharma Europe B.V.
Sylviusweg 62, NL-2333 BE Leiden, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/01/2013 Orphan designation EMA/OD/145/12 (2013)479 of 24/01/2013
08/07/2014 Removal of orphan designation from Community Register